1. Adams CS, Horton WE Jr. Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat Rec. 1998; 250:418–425.
Article
2. Aigner T, Hemmel M, Neureiter D, et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum. 2001; 44:1304–1312.
3. Hashimoto S, Ochs RL, Komiya S, Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 1998; 41:1632–1638.
Article
4. Uysal M, Akpinar S, Bolat F, Cekin N, Cinar M, Cesur N. Apoptosis in the traumatic and degenerative tears of human meniscus. Knee Surg Sports Traumatol Arthrosc. 2008; 16:666–669.
Article
5. Yoon HK, Seo SS, Choi JS, Park JK, Kim YJ. Apoptosis in the meniscus of human osteoarthritic knee. J Korean Orthop Res Soc. 2002; 5:43–54.
6. Gyger O, Botteron C, Doherr M, Zurbriggen A, Schawalder P, Spreng D. Detection and distribution of apoptotic cell death in normal and diseased canine cranial cruciate ligaments. Vet J. 2007; 174:371–377.
Article
7. Murakami H, Shinomiya N, Kikuchi T, Yoshihara Y, Nemoto K. Upregulated expression of inducible nitric oxide synthase plays a key role in early apoptosis after anterior cruciate ligament injury. J Orthop Res. 2006; 24:1521–1534.
Article
8. Hasegawa A, Otsuki S, Pauli C, et al. Anterior cruciate ligament changes in the human knee joint in aging and osteoarthritis. Arthritis Rheum. 2012; 64:696–704.
Article
9. Krammer PH. CD95's deadly mission in the immune system. Nature. 2000; 407:789–795.
Article
10. Waldherr K, Zurbriggen A, Spreng DE, Forterre S. In vitro cytoprotective effects of acetylsalicylic acid, carprofen, meloxicam, or robenacoxib against apoptosis induced by sodium nitroprusside in canine cruciate ligament cells. Am J Vet Res. 2012; 73:1752–1758.
Article
11. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995; 146:75–85.
12. Hashimoto S, Setareh M, Ochs RL, Lotz M. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum. 1997; 40:1749–1755.
Article
13. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992; 119:493–501.
Article
14. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182:311–322.
Article
15. Bonfil RD, Gonzalez AD, Siguelboim D, et al. Immunohistochemical analysis of Ki-67, p21waf1/cip1 and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial. BJU Int. 2001; 88:425–431.
Article
16. Kimura T, Tanaka S, Haruma K, et al. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer. Int J Oncol. 2000; 16:55–64.
Article
17. Michael-Robinson JM, Reid LE, Purdie DM, et al. Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer. Clin Cancer Res. 2001; 7:2347–2356.
18. Kim KW, Kim YS, Ha KY, et al. An autocrine or paracrine Fas-mediated counterattack: a potential mechanism for apoptosis of notochordal cells in intact rat nucleus pulposus. Spine (Phila Pa 1976). 2005; 30:1247–1251.
19. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998; 17:1675–1687.
Article
20. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem. 1999; 274:22532–22538.
Article